SCANDINAVIAN PHARMA GROUP AS
Under liquidation: 08/14/2026, Voluntary liquidation
Utvikle, selge og markedsføre helsefremmende produkter, preparater til
immunforsvaret, naturmidler og kosttilskudd. Videre skal selskapet
drive grossistvirksomhet, netthandel, og kjøp og salg av helsekost,
kosmetikk og livsstilsprodukter, samt investering i andre selskaper og
finansielle instrumenter, og annen beslektet virksomhet.
Utvikle, selge og markedsføre helsefremmende produkter, preparater til
immunforsvaret, naturmidler og kosttilskudd.
Organization
- Chairman of the board
- MH
- Years since formation
- 1 year
- since Jun 5, 2025
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Financials
- Annual total result 2025
- -70,148
- NOK
- Total equity 2025
- -10,148
- NOK
Last update: Aug 14, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
MH | Chairman | - |
SN | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Last update: Jun 23, 2025
Ownership
No available data
Financials
in NOK
Summary
| Year | 2025 |
|---|---|
Total operating income | 0 |
Annual Total Result | -70,148 |
Total assets | 7,954 |
Total liabilities | 18,102 |
Total equity | -10,148 |
P&L
| Year | 2025 |
|---|---|
Total operating income | 0 |
Total operating costs | 69,967 |
Operating result | -69,967 |
Financial income/costs | -181 |
Profit before tax | -70,148 |
Total tax & extraordinary income/cost | 0 |
Annual Total Result | -70,148 |
Balance overview
| Year | 2025 |
|---|---|
Total fixed assets | 0 |
Total current assets | 7,954 |
Total assets | 7,954 |
Short term debt | 18,102 |
Long term debt | 0 |
Total liabilities | 18,102 |
Contributed capital | 60,000 |
Retained earnings | -70,148 |
Total equity | -10,148 |
Total equity and liabilities | 7,954 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises